Back to Search
MARKUS MAPARA, M.D.
M.D.
Medical Oncology Physician
NPI: 1093786766IndividualAccepts Medicare
Education
OTHER
Class of 1990
Research & Publications (20)
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
PMID 15020616·J Clin Oncol·2004
6-review
Osteopetrosis with micro-lacunar resorption because of defective integrin organization.
PMID 19546854·Lab Invest·2009
8-other
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.
PMID 18566220·Mol Cancer Ther·2008
7-preclinical
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
PMID 17095620·Blood·2007
7-preclinical
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.
PMID 17910628·Br J Haematol·2007
8-other
Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
PMID 16737935·Biol Blood Marrow Transplant·2006
7-preclinical
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
PMID 16728283·Exp Hematol·2006
7-preclinical
9th Annual Meeting of the Regional Cancer Consortium for the Biological Therapy of Cancer. 16-18 February 2006, UPMC Herberman Conference Center, Pittsburgh, PA, USA.
PMID 16706609·Expert Opin Biol Ther·2006
7-preclinical
Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1.
PMID 16373662·Blood·2006
8-other
Induction of mixed vs full chimerism to potentiate GVL effects after bone-marrow transplantation.
PMID 15585939·Methods Mol Med·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 161 FT WASHINGTN AVE, HERBERT IRVING PAVILION
NEW YORK, NY 10032 - Phone
- (646) 317-4805
Quick Facts
- NPI
- 1093786766
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile